Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Net Income: 2023-2024

Historic Net Income for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to -$16.1 million.

  • Artiva Biotherapeutics' Net Income fell 41.30% to -$16.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$61.9 million, marking a year-over-year change of. This contributed to the annual value of -$65.4 million for FY2024, which is 127.62% down from last year.
  • According to the latest figures from Q4 2024, Artiva Biotherapeutics' Net Income is -$16.1 million, which was up 2.42% from -$16.5 million recorded in Q3 2024.
  • In the past 5 years, Artiva Biotherapeutics' Net Income ranged from a high of $11.2 million in Q3 2023 and a low of -$16.7 million during Q2 2023.
  • For the 2-year period, Artiva Biotherapeutics' Net Income averaged around -$11.3 million, with its median value being -$15.5 million (2024).
  • The largest annual percentage gain for Artiva Biotherapeutics' Net Income in the last 5 years was 6.90% (2024), contrasted with its biggest fall of 246.84% (2024).
  • Artiva Biotherapeutics' Net Income (Quarterly) stood at -$11.4 million in 2023, then tumbled by 41.30% to -$16.1 million in 2024.
  • Its Net Income stands at -$16.1 million for Q4 2024, versus -$16.5 million for Q3 2024 and -$15.5 million for Q2 2024.